EDAP TMS Past Earnings Performance
Past criteria checks 0/6
EDAP TMS's earnings have been declining at an average annual rate of -71.8%, while the Medical Equipment industry saw earnings growing at 13.4% annually. Revenues have been growing at an average rate of 8% per year.
Key information
-71.8%
Earnings growth rate
-68.7%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 8.0% |
| Return on equity | -37.2% |
| Net Margin | -35.0% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
There's Reason For Concern Over EDAP TMS S.A.'s (NASDAQ:EDAP) Massive 28% Price Jump
Mar 22
Does EDAP TMS (NASDAQ:EDAP) Have A Healthy Balance Sheet?
Mar 03It's A Story Of Risk Vs Reward With EDAP TMS S.A. (NASDAQ:EDAP)
Jan 19Investors Still Waiting For A Pull Back In EDAP TMS S.A. (NASDAQ:EDAP)
Aug 11Is There An Opportunity With EDAP TMS S.A.'s (NASDAQ:EDAP) 20% Undervaluation?
Dec 19EDAP TMS' (NASDAQ:EDAP) Solid Profits Have Weak Fundamentals
Nov 23EDAP TMS stock falls 7% aftermarket on proposed ADS offering
Sep 22EDAP TMS S.A. GAAP EPS of $0.06 beats by $0.09, revenue of $14.97M beats by $1.35M
Aug 24EDAP's Focal One Revenue Is Set To Accelerate
Aug 08Is EDAP TMS (NASDAQ:EDAP) Weighed On By Its Debt Load?
Jul 19Acceleration At EDAP
Jan 11EDAP TMS (NASDAQ:EDAP) Could Easily Take On More Debt
Jan 06The Consensus EPS Estimates For EDAP TMS S.A. (NASDAQ:EDAP) Just Fell A Lot
Nov 25EDAP's HIFU Progress Is Obscured By The Pandemic, But It's Real
Sep 07EDAP's subsidiary names medTech industry veteran Ryan Rhodes as CEO
Jun 15EDAP TMS S.A. (NASDAQ:EDAP) Just Reported Full-Year Earnings And Analysts Are Lifting Their Estimates
Apr 02Analysts Are Betting On EDAP TMS S.A. (NASDAQ:EDAP) With A Big Upgrade This Week
Jan 24
Treatment with EDAP's HIFU ultrasound benefits in prostate cancer patients, study shows
Jan 14New reimbursement rules for HIFU technology to favor EDAP TMS
Dec 09EDAP TMS S.A. EPS misses by $0.02, beats on revenue
Nov 18Revenue & Expenses BreakdownBeta
How EDAP TMS makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 60 | -21 | 34 | 7 |
| 30 Sep 23 | 57 | -21 | 35 | 6 |
| 30 Jun 23 | 57 | -17 | 33 | 6 |
| 31 Mar 23 | 57 | -11 | 30 | 5 |
| 31 Dec 22 | 55 | -3 | 24 | 5 |
| 30 Sep 22 | 53 | 4 | 21 | 4 |
| 30 Jun 22 | 51 | 3 | 20 | 4 |
| 31 Mar 22 | 47 | 0 | 18 | 4 |
| 31 Dec 21 | 44 | 1 | 17 | 3 |
| 30 Sep 21 | 45 | 0 | 15 | 4 |
| 30 Jun 21 | 45 | 0 | 14 | 4 |
| 31 Mar 21 | 44 | 0 | 13 | 4 |
| 31 Dec 20 | 42 | -2 | 14 | 4 |
| 30 Sep 20 | 38 | -3 | 14 | 4 |
| 30 Jun 20 | 39 | -2 | 14 | 4 |
| 31 Mar 20 | 42 | 0 | 15 | 4 |
| 31 Dec 19 | 45 | 2 | 15 | 4 |
| 30 Sep 19 | 46 | 4 | 15 | 4 |
| 30 Jun 19 | 44 | 2 | 15 | 4 |
| 31 Mar 19 | 40 | 0 | 14 | 4 |
| 31 Dec 18 | 39 | 0 | 14 | 4 |
| 30 Sep 18 | 36 | -1 | 13 | 4 |
| 30 Jun 18 | 35 | -1 | 13 | 4 |
| 31 Mar 18 | 36 | -2 | 13 | 4 |
| 31 Dec 17 | 36 | -1 | 13 | 4 |
| 30 Sep 17 | 36 | -2 | 13 | 4 |
| 30 Jun 17 | 37 | 0 | 13 | 4 |
| 31 Mar 17 | 36 | 4 | 12 | 4 |
| 31 Dec 16 | 36 | 4 | 12 | 4 |
| 30 Sep 16 | 37 | 10 | 12 | 3 |
| 30 Jun 16 | 35 | 4 | 11 | 3 |
| 31 Mar 16 | 35 | 2 | 11 | 3 |
| 31 Dec 15 | 32 | -2 | 11 | 3 |
| 30 Sep 15 | 27 | -9 | 10 | 3 |
| 30 Jun 15 | 27 | 2 | 10 | 3 |
| 31 Mar 15 | 25 | -4 | 10 | 3 |
| 31 Dec 14 | 26 | -1 | 10 | 3 |
| 30 Sep 14 | 28 | 2 | 10 | 3 |
| 30 Jun 14 | 27 | -5 | 9 | 3 |
| 31 Mar 14 | 26 | 0 | 9 | 2 |
| 31 Dec 13 | 24 | -5 | 9 | 3 |
| 30 Sep 13 | 25 | -6 | 10 | 3 |
| 30 Jun 13 | 25 | -6 | 10 | 3 |
Quality Earnings: EDAP is currently unprofitable.
Growing Profit Margin: EDAP is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: EDAP is unprofitable, and losses have increased over the past 5 years at a rate of 71.8% per year.
Accelerating Growth: Unable to compare EDAP's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: EDAP is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (6.3%).
Return on Equity
High ROE: EDAP has a negative Return on Equity (-37.21%), as it is currently unprofitable.